AVENGEBIO
AvengeBio is focusing on Cell-Generated Immunotherapies to eradicate solid tumors. It is a developer of a drug delivery platform intended to treat cancer. The company was founded in 2019 and based in Cambridge, Massachusetts.
AVENGEBIO
Industry:
Biotechnology Health Care Medical
Founded:
2019-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.avengebio.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
45 M USD
Technology used in webpage:
U.S. Server Location
Similar Organizations
bttn
bttn is the future of healthcare distribution. Revolutionizing the way that medical supplies are delivered across the world
Mendaera
Mendaera is a platform that addresses inefficiencies in healthcare with advanced technical solutions.
Radish Health
By combining modern technology and medicine, we can give your employees world-class healthcare when and where they want it.
Rupa Health
Rupa Health is a telehealth solution that makes it easier to practice root cause medicine.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Veuu
Veuu is an inclusive and sustainable FinTech ecosystem for healthcare.
Yuvo Health
Yuvo Health is a leading solution to give community health centers an advantage in value-based care.
Current Advisors List
Current Employees Featured
Founder
Investors List
CAM Capital
CAM Capital investment in Series A - AvengeBio
Longitude Capital
Longitude Capital investment in Series A - AvengeBio
Rock Springs Capital
Rock Springs Capital investment in Series A - AvengeBio
Perceptive Advisors
Perceptive Advisors investment in Series A - AvengeBio
Pappas Capital
Pappas Capital investment in Series A - AvengeBio
Longitude Capital
Longitude Capital investment in Seed Round - AvengeBio
Key Employee Changes
| Date | New article |
|---|---|
| 2022-03-28 | Avenge Bio Appoints Claudio Dansky Ullmann, M.D., as Chief Medical Officer |
| 2022-02-22 | Avenge Bio Appoints Douglas Carlson as Chief Operating and Financial Officer |
Official Site Inspections
http://www.avengebio.com
- Host name: 209.182.196.37
- IP address: 209.182.196.37
- Location: Los Angeles United States
- Latitude: 33.956
- Longitude: -118.3887
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90045
More informations about "AvengeBio"
AvengeBio - Crunchbase Company Profile & Funding
Organization. AvengeBio . Connect to CRM . Save . Summary. Financials. People. …See details»
Avenge Bio Company Profile 2024: Valuation, Funding …
Avenge Bio General Information Description. Developer of therapeutics designed to potentially eradicate intractable solid tumors. The company is developing a …See details»
Avenge Bio - Craft
Avenge Bio is a company developing cell-generated immunotherapies to treat solid tumors. It …See details»
Avenge Bio - LinkedIn
Avenge Bio was founded by an experienced team of proven biotech executives to develop …See details»
Avenge Bio - Overview, News & Similar companies | ZoomInfo.com
Avenge Bio contact info: Phone number: (215) 200-9192 Website: www.avengebio.com What …See details»
Avenge Bio - Org Chart, Teams, Culture & Jobs - The Org
View Avenge Bio's up-to-date org chart, open roles, and culture details. Find executives, board …See details»
Avenge Bio Overview | SignalHire Company Profile
Organization Website: avengebio.com : Phone Number: 5082900502: Avenge Bio industries …See details»
AvengeBio - Funding, Financials, Valuation & Investors - Crunchbase
AvengeBio is focusing on Cell-Generated Immunotherapies to eradicate solid tumors. Search …See details»
Avenge Bio - VentureRadar
"Avenge Bio is developing our proprietary, allogeneic LOCOcyteTM platform for precision …See details»
Avenge Bio - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech …See details»
avengebio - Company Profile - Tracxn
Oct 22, 2024 avengebio ranks 268th among 2399 active competitors. 862 of its competitors …See details»
AvengeBio - Contacts, Employees, Board Members, Advisors
Organization. AvengeBio . Connect to CRM . Save . Summary. Financials. People. …See details»
Avenge Bio's Leadership Team - Team members and org chart
The current leadership team at avengebio has experience in the pharmaceutical industry and …See details»
AvengeBio
AvengeBio. Thank you for visiting the website of Avenge Bio. The Company is permanently …See details»
Avenge Bio Announces Closing of $45 Million Series A Financing
NATICK, Mass., Jan. 5, 2022 /PRNewswire/ — Avenge Bio, Inc., a biotechnology company …See details»
Avenge Bio Announces Closing of $45 Million Series A Financing
Jan 5, 2022 Funding to advance lead program into the clinic for treatment of ovarian cancer. …See details»
Tech Transfer From Client Avenge Bio Results in First Dosing
Newark, New Jersey – January 17, 2023 – BioCentriq, Inc.—a New Jersey-based, cell and …See details»
Avenge Bio Announces Closing of $45 Million Series A Financing
Jan 5, 2022 To learn more, visit www.avengebio.com. Media Contact. David Melamed, Ph.D. …See details»
Avenge Bio Announces Closing of $45 Million Series A Financing
NATICK, Mass., Jan. 5, 2022 /PRNewswire/ -- Avenge Bio, Inc., a biotechnology company …See details»
Avenge Bio Receives FDA Orphan Drug Designation for AVB-001 …
Jun 15, 2023 NATICK, Mass. and QUINCY, Mass., June 15, 2023 /PRNewswire/ -- Avenge …See details»